Englewood Health is breaking new ground in women's heart health, and they're doing it with a study that could change the game for women living with heart disease.
Dr. Molly Schultheis, a cardiothoracic surgeon at Englewood Health, is a principal investigator for an international research study called ROMA: Women.
(Sidenote: Dr. Schultheis isn't just any doctor—she’s the only female cardiothoracic surgeon practicing in Bergen County and is one of just 140 female cardiothoracic surgeons in the nation.)
The study she’s leading at Englewood Health aims to increase our understanding of how women respond to coronary artery bypass graft (CABG) surgery.
Now, you might be wondering, what is CABG surgery? It's a procedure that helps improve blood flow to the heart in patients with coronary artery disease. But get this: most of what we know about CABG is based on data from surgeries on men or studies including both men and women.
“Understanding how women’s physiology uniquely responds to procedures used to restore blood flow is incredibly important as we focus on continuously improving outcomes for women with heart disease,” says Dr. Schultheis.
So, Dr. Schultheis and her team are diving deep into the differences. They're comparing two methods of CABG surgery in women: multiple arterial grafting (MAG) and single arterial grafting (SAG).
Englewood Health is leading the pack in enrolling participants for this important study and have enrolled more women than any other health system in New Jersey.
So, next time you're at Englewood Health, give a little shout-out to Dr. Schultheis and her team. They're not just changing lives—they're changing the game for women's heart health everywhere.
To learn more about this exciting study, check out clinicaltrials.gov .
Englewood Health
350 Engle Street
Englewood, NJ
